Reduced Expression of Laminin-5 in Corneal Epithelial Cells Under High Glucose Condition
Overview
Affiliations
Purpose: Laminin-5 (alpha3, beta3, gamma2 chains) is a major component of corneal basement membrane and has a crucial role in corneal epithelial cell adhesion. On the other hand, diabetic keratopathy has a varied degree of adhesive disturbance in corneal epithelial cells. Therefore, in this study, we investigated whether a high glucose condition altered the expression of laminin-5 in corneal epithelial cells in vitro.
Methods: Human corneal epithelial (HCE) cells were cultured in either normal (5 mmol/L) or high glucose (30 mmol/L) medium for 5 passages before being used in experiments. We first examined the effect of a high glucose condition on the expression of mRNA and proteins for 3 chains of laminin-5 in HCE cells by semiquantitative reverse transcriptase-polymerase chain reaction, Western blotting analysis, and immunofluorescence staining. Second, we tried a cell detachment assay. After 5 days of incubation in high or normal glucose medium, HCE cells were treated with a solution of 0.05% trypsin and EDTA (0.2 mmol/L), pH = 8. The number of detached cells at different times after treatment was determined using a cell count machine.
Results: We found that alpha3 chain expression was reduced at the mRNA level in a high glucose condition, whereas beta3 and gamma2 chains showed no change. The high glucose condition induced the inhibition in the synthesis of 190-kd, 160-kd alpha3 chain and 105-kd gamma2 chain proteins of laminin-5. The adhesion capacity of HCE cells in the high glucose medium was weaker than that of HCE cells in normal glucose medium. Soluble laminin-5 rescued the detachment of HCE cells in high glucose medium.
Conclusion: The loss of homeostatic levels of laminin-5 under a high glucose condition may correlate to weaken epithelial cell adhesion, resulting in the clinical manifestation of diabetic keratopathy.
The Role of Immune Cells and Signaling Pathways in Diabetic Eye Disease: A Comprehensive Review.
Barone V, Surico P, Cutrupi F, Mori T, Gallo Afflitto G, Di Zazzo A Biomedicines. 2024; 12(10).
PMID: 39457658 PMC: 11505591. DOI: 10.3390/biomedicines12102346.
Diabetic Keratopathy: Redox Signaling Pathways and Therapeutic Prospects.
Buonfiglio F, Wasielica-Poslednik J, Pfeiffer N, Gericke A Antioxidants (Basel). 2024; 13(1).
PMID: 38247544 PMC: 10812573. DOI: 10.3390/antiox13010120.
Peterson C, Chandler H Mol Cell Endocrinol. 2022; 548:111611.
PMID: 35231580 PMC: 9053186. DOI: 10.1016/j.mce.2022.111611.
Glucose-impaired Corneal Re-epithelialization Is Promoted by a Novel Derivate of Dimethyl Fumarate.
Giurdanella G, Longo A, Salerno L, Romeo G, Intagliata S, Lupo G Antioxidants (Basel). 2021; 10(6).
PMID: 34067436 PMC: 8224583. DOI: 10.3390/antiox10060831.
Li Q, Chen J, Li Y, Chen T, Zou J, Wang H Medicine (Baltimore). 2017; 96(32):e7773.
PMID: 28796073 PMC: 5556239. DOI: 10.1097/MD.0000000000007773.